UBS Group »

Iovance Biotherapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.0M 857k 8.13
2023-09-30 $1.1M 241k 4.55
2023-06-30 $3.3M 470k 7.04
2023-03-31 $2.6M 427k 6.11
2022-12-31 $5.1M 798k 6.39
2022-09-30 $1.0M 106k 9.58
2022-06-30 $1.0M 95k 11.04
2022-03-31 $5.9M 360k 16.52
2021-12-31 $4.2M 220k 19.09
2021-09-30 $4.8M 196k 24.65
2021-06-30 $0 63k 0.00
2021-03-31 $3.1M 98k 31.65
2020-12-31 $4.0M 86k 46.38
2020-09-30 $2.4M 72k 32.92
2020-06-30 $1.2M 45k 27.44
2020-03-31 $832k 28k 29.94
2019-12-31 $4.3M 156k 27.67
2019-09-30 $6.8M 376k 18.20
2019-06-30 $3.2M 132k 24.52
2019-03-31 $98k 10k 9.56
2018-12-31 $2.4M 270k 8.86
2018-09-30 $512k 46k 11.22
2018-06-30 $95k 7.4k 12.92
2018-03-31 $1.0M 61k 16.99
2017-12-31 $11k 1.4k 7.88
2017-09-30 $62k 8.0k 7.75
2017-06-30 $67k 9.1k 7.38